tiprankstipranks
Cue Biopharma (CUE)
:CUE
US Market

Cue Biopharma (CUE) Technical Analysis

Compare
598 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
6Neutral
15Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cue Biopharma’s (CUE) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Cue Biopharma is a Sell.
Cue Biopharma’s (CUE) 20-Day exponential moving average is 1.04, while Cue Biopharma’s (CUE) share price is $0.92, making it a Sell.
Cue Biopharma’s (CUE) 50-Day exponential moving average is 1.14, while Cue Biopharma’s (CUE) share price is $0.92, making it a Sell.

Cue Biopharma (CUE) Pivot Points

Mar 30, 2025, 03:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.93
0.95
0.98
1.00
1.03
1.05
1.08
Fibonacci
0.95
0.97
0.98
1.00
1.02
1.03
1.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cue Biopharma (CUE) Moving Averages

Mar 30, 2025, 03:07 AM
Period
Simple
Exponential
MA5
0.99Sell
0.97Sell
MA10
0.98Sell
0.99Sell
MA20
1.02Sell
1.04Sell
MA50
1.21Sell
1.14Sell
MA100
1.23Sell
1.18Sell
MA200
1.09Sell
1.21Sell
Cue Biopharma’s (CUE) 10-Day exponential moving average is 0.99, while Cue Biopharma’s (CUE) share price is $0.92, making it a Sell.
Cue Biopharma’s (CUE) 100-Day exponential moving average is 1.18, while Cue Biopharma’s (CUE) share price is $0.92, making it a Sell.
Cue Biopharma’s (CUE) stock price is $0.92 and Cue Biopharma’s (CUE) 50-day simple moving average is 1.21, creating a Sell signal.
Cue Biopharma’s (CUE) stock price is $0.92 and Cue Biopharma’s (CUE) 100-day simple moving average is 1.23, creating a Sell signal.
Cue Biopharma’s (CUE) stock price is $0.92 and Cue Biopharma’s (CUE) 200-day simple moving average is 1.09, creating a Sell signal.

Cue Biopharma (CUE) Technical Indicators

Mar 30, 2025, 03:07 AM
Name
Value
Implied Action
RSI (14)
33.50
Neutral
STOCH (9,6)
40.71
Neutral
STOCHRSI (14)
25.73
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
21.97
Neutral
Williams %R
-96.15
Buy
CCI (14)
-88.64
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
38.20
Neutral
ROC
-10.68
Sell
Cue Biopharma’s (CUE) Relative Strength Index (RSI) is 33.50, creating a Neutral signal.
Cue Biopharma’s (CUE) Trend Strength Indicator (ADX) is 21.97, creating a Neutral signal.
Cue Biopharma’s (CUE) Commodity Channel Index (CCI) is -88.64, creating a Neutral signal.
Cue Biopharma’s (CUE) Price Rate of Change (ROC) is -10.68, creating a Sell signal.

FAQ

Is CUE a Buy, Hold, or Sell?
Based on CUE’s technical indicators, CUE is a Strong Sell.
    What is CUE’s RSI (14)?
    CUE’s RSI (14) is 33.50, which suggests CUE is a Neutral.
      What is CUE’s MACD?
      CUE’s MACD is -0.07, which suggests CUE is a Sell.
        What is CUE’s 5-day moving average?
        CUE’s 5-day moving average is 0.99, which suggests CUE is a Sell.
          What is CUE’s 20-day moving average?
          CUE 20-day moving average is 1.02, which suggests CUE is a Sell.
            What is CUE’s 50-day moving average?
            CUE’s 50-day moving average is 1.21, which suggests CUE is a Sell.
              What is CUE’s 200-day moving average?
              CUE’s 200-day moving average is 1.09, which suggests CUE is a Sell.
                What is CUE’s Williams % R (14)?
                CUE’s Williams % R (14) is -96.15, which suggests CUE is a Buy.
                  What is CUE’s CCI (14)?
                  CUE’s CCI (14) is -88.64, which suggests CUE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis